UNSPSC 51283411: Piroxicillin

This classification denotes a penicillin antibiotic with the molecular formula C27H28N8O9S2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier HPI5A94GD9, chemically known as (2s,5r,6r)-6-((r)-2-(p-hydroxyphenyl)-2-(3-(4-hydroxy-2-(p-sulfamoylanilino)-5-pyrimidinyl)ureido)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid but generally known as piroxicillin, which bears US NIH Compound Identifier 3047855.

UNSPSC 51283411 Piroxicillin, a Commodity code, shows limited recent activity with mismatch between the code's nominal scope and actual state and local procurement. The recent opportunities tagged under this code involve naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, medical and first aid supplies for emergency response, and generic pharmaceuticals and over-the-counter products—none of which align with piroxicillin as an antibiotic pharmaceutical. The issuing bodies span county health departments, state health and human services commissions, municipal fire departments, and multi-state cooperative purchasing alliances, indicating fragmentation across health, emergency services, and general pharmaceutical procurement functions rather than focused activity around a single drug class.

Geographic spread includes Florida, Texas, Minnesota, and Oregon based on the recent solicitation record. Representative recent opportunities include Seminole County's July 2026 IFB for naloxone and drug deactivation systems (1,900 units of naloxone, 800 deactivation systems annually, delivery to Sanford, Florida); Texas Health and Human Services Commission's April 2026 RFI for direct-to-manufacturer prescription programs; the City of Tampa's March 2026 IFB for medical and first aid supplies for the Tampa Fire Department Rescue Division (estimated contract amount $700,000.00, sheltered for certified Small Local Business Enterprises with a 5% bid discount); and Minnesota's MMCAP January 2026 RFP for generic multi-source pharmaceuticals and OTC products across state and local facilities in Minnesota and Oregon, due March 26, 2026. The code does not show substantial recent procurement activity specifically for piroxicillin or closely related products.